USPTO serial 75383141
PHARMING HEALTH CARE PRODUCTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHNSON, AISHA CLARKE
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PHARMING HEALTH CARE PRODUCTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
2333 CA Leiden, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DAVID E. SIPIORA
DAVID E SIPIORA TOWNSEND AND TOWNSEND AND CREW LLPTOW EMBARCADERO CTR 8TH FLSAN FRANCISCO, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, including pharmaceutical preparations using proteins and enzymes extracted or expressed by genetically modified organisms for use in the treatment of genetic deficiencies or disorders, diseases caused by genetic deficiencies or disorders, auto-immune diseases, infectious diseases, immune system related diseases or immune system mediated disorders, and other human diseases, disorders, or conditions; enzyme preparations, including enzyme preparations for enzyme replacement therapy; blood factors and plasma expanders for use in the treatment of genetic deficiencies or disorders or diseases caused by genetic deficiencies or disorders, or for use as plasma substitutes; human antibodies, including monoclonal antibodies; proteins related to connective tissue repair; sanitary preparations, including antibacterial handwash, antiseptics, general purpose germicides, sanitizers for hospital, household and laboratory uses; veterinary preparations including veterinary preparations using proteins and enzymes extracted or expressed by genetically modified organisms for use in the treatment of genetic deficiencies or disorders, diseases caused by genetic deficiencies or disorders, auto-immune diseases, infectious diseases, immune system related diseases or immune system mediated disorders, and other diseases, disorders, or conditions in livestock, domestic pets and zoological animals; dietetic substances, including diet foods, foods for medically restricted diets, foods for diabetics, food for enteral feeding, food supplements, meal replacement drinks and powders, food for babies; medical plasters, corn plasters; materials for dressings and grafts, including wound dressings and grafts, burn dressings and grafts, surgical dressings and grafts, adhesive bandages and grafts, surgical bandages, bandages for skin wounds, gauze; materials for stopping teeth, dental wax; all purpose disinfectants, disinfectants for hospital, veterinary and laboratory equipment and instruments; preparations for destroying vermin for agricultural, domestic, commercial and laboratory use; fungicides for agricultural, domestic, commercial and laboratory use; herbicides for agricultural, domestic, commercial and laboratory use | ACTIVE | — |
| 010 | surgical instruments and apparatus for use in genetic engineering and biotechnology; medical instruments and apparatus for use in genetic engineering, biotechnology and cosmetic surgery; dental instruments and apparatus for use in genetic engineering and biotechnology; veterinary instruments and apparatus for use in genetic engineering and biotechnology; artificial limbs, eyes, teeth and skin; orthopedic articles, including bone materials, bone replacements, joints, and cartilage ingaments; suture materials | ACTIVE | — |
| 042 | genetic research; genealogical research; technical advice and analysis services in the fields of genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances; animal breeding; material research in the fields of genetic engineering, pharmaceutical production and isolation of pharmaceuticals; chemical analysis; becteriologic research; chemical research; material testing; veterinary assistance, including production of transgenic animals; sanitation consulting; quality control for others; research in the fields of genetics or genealogy, chemicals, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances; research and development for new products for others in the fields of genetics or genealogy, chemicals, pharmaceutical production, isolation of pharmaceutical, and nutritive and dietetic substances; genetic engineering services; design and testing for new product development,; design and testing of new products for others; design for others in the fields of genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances; product development consultation; product development for others; all the aforesaid services especially related to the field of biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharming Holding N.V.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named PHARMING HEALTH CARE PRODUCTS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 22, 2004 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 22, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 13, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2003 | CFIT | CASE FILE IN TICRS | — |
| Mar 14, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 1999 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 28, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 1998 | DOCK | ASSIGNED TO EXAMINER | — |